$3 billion in sales for NBTY
Supplement manufacturing giant NBTY predicted its sales would top $3 billion in the fiscal year that ended September 30.
NBTY said the sales figure would range from $3.05 billion to $3.07 billion and consolidated EBITDA for the fiscal year ended September 30, 2012 is forecast to range between $556 million and $566 million. These figures compared with a final sales figure in 2011 of $2.96 billion.